checkAd
    Startseite > Aktien > MAIA Biotechnology > Nachrichten
    MAIA Biotechnology Aktie
    2,9400
     
    USD
    +9,70 %
    +0,2600 USD
    Letzter Kurs 27.04.24 NYSE Arca
    2,8900
     
    USD
    100 STK
    Geldkurs 26.04.24
    2,9500
     
    USD
    100 STK
    Briefkurs 26.04.24
    ISIN: US5526411021 · WKN: A3DGQQ · SYM: MAIA · USA

    Neueste Nachrichten

    MAIA Biotechnology Announces $1.00 Million Private Placement
    23.04.24 · Business Wire (engl.) · MAIA Biotechnology
    MAIA Biotechnology to Present at Two Investor Conferences in April 2024
    05.04.24 · Business Wire (engl.) · MAIA Biotechnology
    MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero
    28.03.24 · Business Wire (engl.) · MAIA Biotechnology
    MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
    26.03.24 · Business Wire (engl.) · MAIA Biotechnology
    MAIA Biotechnology Announces $1.33 Million Private Placement
    26.03.24 · Business Wire (engl.) · MAIA Biotechnology
    MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement
    22.03.24 · Business Wire (engl.) · MAIA Biotechnology
    MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board
    21.03.24 · Business Wire (engl.) · MAIA Biotechnology
    MAIA Biotechnology to Participate in the 36th Annual ROTH Conference
    07.03.24 · Business Wire (engl.) · MAIA Biotechnology
    MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting
    06.03.24 · Business Wire (engl.) · MAIA Biotechnology
    MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients
    06.03.24 · Business Wire (engl.) · MAIA Biotechnology
    MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders
    05.03.24 · Business Wire (engl.) · MAIA Biotechnology
    MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor
    27.02.24 · globenewswire · MAIA Biotechnology